微创与开放RAMPS治疗胰体尾导管腺癌的单中心回顾性比较
该单中心回顾性研究纳入2012年8月至2018年3月期间接受开放或腹腔镜RAMPS的左侧PDAC患者,排除联合器官或血管切除、远处转移及开放转腹腔镜者。结果显示两组在人口学特征、围术期并发症、R0切缘率、淋巴结清扫数目及远期生存上均无显著差异,提示腹腔镜RAMPS技术可行且肿瘤学结果与开放RAMPS相当。
要点
- 腹腔镜RAMPS与开放RAMPS在R0切缘率、淋巴结清扫数目及远期生存上无显著差异。
- 腹腔镜RAMPS组R0切缘率:切缘92%,腹膜后切缘92%;开放组分别为91.3%和95.65%。
- 两组中位DFS和中位OS无显著差异,提示腹腔镜RAMPS肿瘤学安全性相当。
核心结论
- 腹腔镜RAMPS技术可行,且远期肿瘤学结果与开放RAMPS相当。
研究设计与样本
- 单中心回顾性研究,前瞻性数据库回顾2012年8月至2018年3月接受开放或腹腔镜RAMPS的左侧PDAC患者,排除联合器官或血管切除、远处转移及开放转腹腔镜者,共纳入48例(腹腔镜组25例,开放组23例)。
主要发现
- 两组人口学特征及围术期并发症无显著差异。
- 腹腔镜RAMPS组R0切缘和腹膜后切缘均达到R0者23/25(92%);开放RAMPS组R0切缘21/23(91.3%),R0腹膜后切缘22/23(95.65%)。
- 两组淋巴结清扫数目无显著差异(15.84 vs 18.22;P=0.268)。
- 两组中位DFS相似(18.11个月 vs 20.00个月,P=0.999)。
- 腹腔镜RAMPS组中位OS为24.53个月,开放RAMPS组为28.73个月(P=0.633)。
临床怎么用
- 在严格筛选的左侧PDAC患者中,腹腔镜RAMPS可作为开放RAMPS的可行替代方案,肿瘤学短期及远期结果相当。
局限性
- 单中心回顾性研究,样本量较小(48例),可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Radical antegrade modular pancreatosplenectomy (RAMPS) was proposed a decade ago with the aim to achieve higher R0 tangential margin and radical N1 lymph node resection for left-sided pancreatic adenocarcinoma (PDAC), which has been widely accepted worldwide at present. Laparoscopic RAMPS (Lap-RAMPS) has been attempted for PDAC during last several years, however, no outcomes evaluation by comparison between laparoscopic vs open RAMPS has been reported yet. MATERIALS AND METHODS: From August, 2012 to March, 2018, patients undergoing open or lap-RAMPS for the diagnosis of left-sided PDAC were reviewed from a prospective database. Patients excluded if they were related with combined organs or vessels resection, systematic metastasis as well as conversion from open RAMPS to lap RAMPS. The surgical and oncologic outcomes were compared. RESULTS: A total of 48 PDAC patients were enrolled (25 underwent lap-RAMPS and 23 underwent open-RAMPS). There were no significant differences in demographic or perioperative morbidity. In the lap-RAMPS group, R0 transection margin and retroperitoneal margin were both achieved in 23 of 25 patients (92%). In the open RAMPS group, R0 transection margin was achieved in 21 of 23 patients (91.3%), R0 retroperitoneal margin was 22 of 23 patients (95.65%). There were no differences in pathological examinations. The number of lymph node (LN) retrieved between lap-RAMPS and open- RAMPS group was not significant difference (15.84 vs 18.22; P = 0.268). Median disease-free survival (DFS) was analogous in two groups (18.11 m vs 20.00 m, P = 0.999). Median overall survival (OS) was 24.53 m in lap-RAMPS group and 28.73 m in the open-RAMPS group (P = 0.633). CONCLUSIONS: Lap-RAMPS is technically feasible, and has comparable long-term oncological outcome with open-RMAPS.
引用
- Zhang H, Li Y, Liao Q, et al. Comparison of minimal invasive versus open radical antegrade modular pancreatosplenectomy (RAMPS) for pancreatic ductal adenocarcinoma: a single center retrospective study. Surg Endosc. 2020. PMID: 33033915. doi:10.1007/s00464-020-07938-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。